Abstract
Background
There is increasing evidence to implement multiparametric magnetic resonance imaging (mpMRI) for biopsy-naive men with clinically suspected prostate cancer (PCa). This will reduce the number of unnecessary trans rectal ultrasound biopsies (TRUS-Bx) performed and reduce the number of indolent cancers diagnosed.
Aims
To assess current clinical practices for investigating clinically suspected prostate cancer in Ireland and determine if private health insurance providers are offering mpMRI scans in biopsy-naive men.
Methods
Each health insurance provider procedure code was reviewed. The indications and requirements for prostate mpMRI in the setting of diagnosis, staging, surveillance, and recurrence were assessed for each health care provider. Current practices adopted by accredited referral clinics for suspected prostate cancer were reviewed.
Results
Two of the three leading health insurance providers, which between them cover 46% of the private health insurance market in Ireland, provide pre-biopsy mpMRI cover as of April 2019. This leaves almost half of those insured with no accessibility to pre-biopsy mpMRI. This is in contrast to the majority of public NCCP hospitals that offer pre-biopsy mpMRI for clinically suspected prostate cancer.
Conclusions
Pre-biopsy mpMRI for clinically suspected prostate cancer is emerging as a standard of practice in Ireland. International guidelines are also changing to reflect latest clinical trial evidence. Private health insurance providers should amend their policies to reflect current clinical practices already adopted in the public sector.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
van der Leest M, Cornel E, Israël B, Hendriks R, Padhani AR, Hoogenboom M, et al. Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naïve men with elevated prostate-specific antigen: a large prospective multicenter clinical study. Eur Urol [Internet]. 2018 Nov 23 [cited 2018 Dec 18]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/30477981
Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med [Internet]. 2016 Oct 13 [cited 2018 Dec 29];375(15):1415–1424. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27626136
Wilt TJ, Jones KM, Barry MJ, Andriole GL, Culkin D, Wheeler T, et al. Follow-up of prostatectomy versus observation for early prostate cancer. N Engl J Med [Internet]. 2017 Jul 13 [cited 2018 Dec 29];377(2):132–142. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28700844
Van Hemelrijck M, Ji X, Helleman J, Roobol MJ, van der Linden W, Nieboer D, et al. Reasons for discontinuing active surveillance: assessment of 21 centres in 12 countries in the Movember GAP3 Consortium. Eur Urol [Internet]. 2018 Oct 29 [cited 2018 Dec 30]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/30385049
Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM (2011 Nov) Complications after prostate biopsy: data from SEER-Medicare. J Urol 186(5):1830–1834
Candas B, Cusan L, Gomez JL, Diamond P, Suburu RE, Lévesque J et al (2000 Sep 15) Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer. Prostate 45(1):19–35
Gershman B, Boorjian SA, Borghesi M, Ahmed H, Nam R, Schaeffer E, et al. 2017 Platinum priority-review-prostate cancer complications after systematic, random, and image-guided prostate biopsy. [cited 2018 Dec 28];366–7. Available from: https://doi.org/10.1016/j.eururo.2016.08.004
Nam RK, Saskin R, Lee Y, Liu Y, Law C, Klotz LH et al (2013 Jan) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 189(1):S12–S18
Walker JT, Singla N, Roehrborn CG (2016) Reducing infectious complications following transrectal ultrasound-guided prostate biopsy: a systematic review. Rev Urol 18(2):73–89
EAU. EAU guidelines [Internet]. Edn. prese. EAU Guidelines Office; 2018. Available from: http://uroweb.org/guideline/prostate-cancer
Bjurlin MA, Carroll PR, Eggener S, Fulgham PF, Pinto PA, Rubenstein JN, et al 2018 MRI of the prostate, standard operating procedure (SOP) [Internet]. Available from: https://www.auanet.org/guidelines/mri-of-the-prostate-sop
NICE. Prostate cancer: diagnosis and management (update) [Internet]. 2018. Available from: https://www.nice.org.uk/guidance/indevelopment/gid-ng10057
Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK et al (2017 Feb 25) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet (London, England) 389(10071):815–822
Alberts AR, Roobol MJ, Verbeek JFM, Schoots IG, Chiu PK, Osses DF et al (2018 Aug) Prediction of high-grade prostate cancer following multiparametric magnetic resonance imaging: improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators. Eur Urol 3(0):0
NCRI. Cancer trends - prostate cancer [Internet]. 2016 [cited 2019 Feb 10]. Available from: www.ncri.ie
National Cancer Registry. Cancer in Ireland 1994-2014: Annual Report of the National Cancer Registry [Internet]. Cork; 2016 [cited 2019 Feb 2]. Available from: www.ncri.ie
The Health Insurance Authority. Competition in the Irish private health insurance market executive summary [Internet]. 2007 [cited 2019 Feb 2]. Available from: https://www.hia.ie/sites/default/files/Competition-Exec-Summary-2007.pdf
Department of Health. Health in Ireland key trends 2018 [Internet]. Dublin; 2018 [cited 2019 Feb 2]. Available from: https://health.gov.ie/wp-content/uploads/2018/12/Key-Health-Trends-2018.pdf
Oba A, Nakaya N, Saito-Nakaya K, Hasumi M, Takechi H, Arai S, et al. Psychological distress in men with prostate cancer and their partners before and after cancer diagnosis: a longitudinal study. Jpn J Clin Oncol [Internet]. 2017 Aug 1 [cited 2019 Feb 2];47(8):735–742.
Brown LC, Ahmed HU, Faria R, El-Shater Bosaily A, Gabe R, Kaplan RS et al (2018 Jul) Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study. Health Technol Assess (Rockv) 22(39):1–176
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical approval
Not applicable
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yap, L.C., Lynch, T.H. & Manecksha, R.P. MRI for clinically suspected prostate cancer—the disparity between private and public sectors. Ir J Med Sci 189, 461–465 (2020). https://doi.org/10.1007/s11845-019-02103-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-019-02103-7